)
Adocia (ADOC) investor relations material
Adocia Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Cash position of €9.7 million as of June 30, 2026, with a shareholder loan agreement extending runway to early Q2 2027.
Focused on advancing BioChaperone® Lispro marketing authorization in China and expanding BioChaperone® platform applications.
Board of Directors refreshed with new Chairman, two new Directors, and a Board Observer.
Financial highlights
Operating revenue for H1 2026 was €1.3 million, mainly from a BioChaperone® feasibility study; other income (mainly research tax credit) also €1.3 million.
Operating expenses decreased to €9.3 million, down €1.8 million year-over-year, due to lower share-based payments, FX impacts, and personnel costs.
Net loss improved to €8.6 million from €9.3 million in H1 2025.
Cash burn for H1 2026 was €10.1 million, compared to €11.8 million in H1 2025.
Net financial debt (excluding IFRS 16) included €0.7 million in state-guaranteed loans (fully repaid by August 2026) and €0.7 million in shareholder advances.
Outlook and guidance
Cash runway secured until early Q2 2027, assuming full use of the shareholder loan and no new partnership revenue.
Actively seeking additional financing and strategic partnerships while reducing costs.
Material uncertainty regarding going concern disclosed in the half-year report.
- Revenue up, net loss down, and cash runway extended to Q2 2026 with major clinical milestones ahead.ADOC
H2 2024 - Strong cash position and positive R&D progress support strategic focus on BioChaperone®.ADOC
Q2 2026 TU - Innovative peptide platforms drive growth in diabetes and obesity therapeutics.ADOC
Investor presentation - BC Lispro/BCLIS achieved superior postprandial and daily glucose control with non-inferior HbA1c.ADOC
Study result - Cash runway secured to Q2 2027; BioChaperone® prioritized after positive study results.ADOC
Q1 2026 TU - Pipeline advances and new financing extend cash runway to Q2 2027 despite wider net loss.ADOC
H2 2025 - Strong clinical progress, robust cash, and leadership changes mark a transformative quarter.ADOC
Q4 2025 TU - H1 2025 saw higher revenue and cash inflow, but net loss increased to €9.3 million.ADOC
H1 2025 - Net loss €8.9M, €10.3M cash, funding to Q3 2025, key programs advancing.ADOC
H1 2024
Next Adocia earnings date
Next Adocia earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)